CheckMyRecalls

Granules Pharmaceuticals Inc. recalls Trazodone Hydrochloride

Published
11 Feb 2026
Units affected
71424 bottles.
Agency
FDA
Country
United States

The hazard

Presence of Foreign Tablets/Capsules

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Brand / company
Granules Pharmaceuticals Inc.
Codes / lots
Batch # 6160008A, Exp Date: 12/31/2026
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.